Skip to main content

CAPITAL FUND MANAGEMENT S.A.

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 1323645 PARIS, I0

Position in BCRX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$333,270
-$210,683 QoQ
Shares Held
33,327
-41.7% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#181
of 316 holders
Holding Since
Dec 2021
12 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in BCRX Over Time

Shares Held

Position Value (USD)

Derivatives in BCRX

reported options exposure · as of Dec 31, 2021
CallValue
$265,920
CallShares
19,200
PutValue
$812,995
PutShares
58,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CAPITAL FUND MANAGEMENT S.A. holds $95,675,665 across 11 Drug Manufacturers - Specialty & Generic names. BCRX ranks #11 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BCRX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $333,270 33,327
2026-03-31 $543,953 57,138
2025-06-30 $465,140 51,913
2024-12-31 $446,139 59,327
2024-09-30 $2,717,874 357,615
2024-06-30 $1,529,797 247,540
2024-03-31 $1,074,577 211,531
2023-09-30 $869,268 122,778
2023-06-30 $1,194,603 169,688
2023-03-31 $544,551 65,294
2022-03-31 $1,910,631 117,505
2021-12-31 $812,995 58,700
2021-12-31 $265,920 19,200